CHPT(CHPT)
CHPT
Q3 2026 EPS Estimate
$-0.80
Sep 2, 2026 · Reports after close
Revenue Estimate
$105M
FY2031E EPS$1.57
Analyst Sentiment
Wall St. Consensus
Hold18 analysts·Moderate coverage
54
Score
5 Buy (28%)11 Hold (61%)2 Sell (11%)
Rating Breakdown
Strong Buy
00%
Buy
528%
Hold
1161%
Sell
211%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$8.00
+34.5%
Consensus
$8.00
+34.5%
Bull
$8.00
+34.5%
12-Month Target Range18 analysts
$8.00$8.00$8.00
Current $5.95Consensus
Current Price
$5.95
Upside to Consensus
$2.05
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+5.65%
EPS—
FY2028
Rev+13.94%
EPS—
FY2029
Rev+22.52%
EPS—
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $430M | $489M | $600M | $703M | $814M |
| Low | $424M | $487M | $589M | $684M | $792M |
| High | $436M | $492M | $607M | $720M | $833M |
| EBITDA Avg | $-249M | $-283M | $-347M | $-407M | $-471M |
| Low | $-252M | $-285M | $-351M | $-417M | $-482M |
| High | $-246M | $-282M | $-341M | $-396M | $-458M |
| EBIT Avg | $-278M | $-317M | $-388M | $-455M | $-526M |
| Low | $-282M | $-318M | $-393M | $-466M | $-539M |
| High | $-275M | $-315M | $-381M | $-442M | $-512M |
| Net Income Avg | $-142M | $-106M | $-56M | $-2M | $37M |
| Low | $-158M | $-132M | $-93M | $-2M | $35M |
| High | $-127M | $-81M | $-19M | $-1M | $38M |
| EPS Avg | $-6.08 | $-4.56 | $-2.38 | $-0.07 | $1.57 |
| Low | $-6.75 | $-5.63 | $-3.96 | $-0.07 | $1.51 |
| High | $-5.42 | $-3.45 | $-0.82 | $-0.06 | $1.62 |
| Analysts (Rev / EPS) | 6 / 4 | 4 / 4 | 3 / 3 | 1 / 1 | 1 / 1 |
Quarterly
| Metric | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 | Q3 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $109M | $113M | $115M | $120M | $125M | $128M | $141M | $146M |
| Low | $107M | $111M | $112M | $117M | $121M | $124M | $137M | $142M |
| High | $111M | $116M | $118M | $123M | $128M | $131M | $145M | $149M |
| EBITDA Avg | $-63M | $-66M | $-67M | $-69M | $-72M | $-74M | $-82M | $-84M |
| Low | $-64M | $-67M | $-68M | $-71M | $-74M | $-76M | $-84M | $-86M |
| High | $-62M | $-64M | $-65M | $-68M | $-70M | $-72M | $-79M | $-82M |
| EBIT Avg | $-71M | $-73M | $-75M | $-77M | $-81M | $-83M | $-91M | $-94M |
| Low | $-72M | $-75M | $-76M | $-79M | $-83M | $-85M | $-94M | $-97M |
| High | $-69M | $-71M | $-73M | $-75M | $-79M | $-81M | $-89M | $-92M |
| Net Income Avg | $-36M | $-33M | $-38M | $-35M | $-34M | $-32M | $-28M | $-26M |
| Low | $-42M | $-34M | $-39M | $-37M | $-35M | $-33M | $-29M | $-27M |
| High | $-29M | $-31M | $-37M | $-34M | $-33M | $-31M | $-27M | $-25M |
| EPS Avg | $-1.45 | $-1.32 | $-1.55 | $-1.44 | $-1.37 | $-1.28 | $-1.13 | $-1.06 |
| Low | $-1.69 | $-1.36 | $-1.60 | $-1.48 | $-1.42 | $-1.33 | $-1.17 | $-1.09 |
| High | $-1.19 | $-1.28 | $-1.50 | $-1.39 | $-1.33 | $-1.24 | $-1.09 | $-1.02 |
| Analysts (Rev / EPS) | 5 / 3 | 4 / 1 | 4 / 1 | 4 / 1 | 4 / 1 | 3 / 1 | 3 / 1 | 3 / 1 |